Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Mayo Clin Proc. 2013 Jan;88(1):56–67. doi: 10.1016/j.mayocp.2012.08.020

Table 1.

Age- and sex-specific prevalence (per 100 population) of the 20 most common chronic disease groups in the 2009 Olmsted County, MN, population (N=142,377)a

Chronic disease group Age (years)
All ages
0–18
19–29
30–49
50–64
65+
Crudeb
Standardizedc
No. % No. % No. % No. % No. % No. % No. %
Skin disorders
 Both sexes 12,703 32.95 9170 38.26 15,652 41.27 12,390 50.39 11,398 65.75 61,313 43.06 61,313 42.67
 Men 6232 31.78 3247 31.41 5923 33.11 5221 45.42 4980 66.11 25,603 38.29 25,603 38.43
 Women 6471 34.15 5923 43.45 9729 48.55 7169 54.76 6418 65.47 35,710 47.29 35,710 46.90

Osteoarthritis and joint disorders
 Both sexes 5580 14.47 6044 25.22 13,122 34.60 12,275 49.92 10,971 63.28 47,992 33.71 47,992 33.58
 Men 2859 14.58 2752 26.62 5832 32.60 5223 45.43 4273 56.72 20,939 31.32 20,939 31.72
 Women 2721 14.36 3292 24.15 7290 36.38 7052 53.87 6698 68.33 27,053 35.83 27,053 35.13

Back problems
 Both sexes 2193 5.69 4890 20.40 11,054 29.15 8287 33.70 7692 44.37 34,116 23.96 34,116 23.90
 Men 1050 5.35 1653 15.99 4588 25.65 3508 30.52 2966 39.37 13,765 20.59 13,765 21.12
 Women 1143 6.03 3237 23.75 6466 32.27 4779 36.50 4726 48.21 20,351 26.95 20,351 26.48

Disorders of lipid metabolism
 Both sexes 135 0.35 704 2.94 7261 19.15 11,948 48.59 12,143 70.05 32,191 22.61 32,191 22.39
 Men 75 0.38 330 3.19 4247 23.74 6110 53.15 5463 72.52 16,225 24.27 16,225 24.74
 Women 60 0.32 374 2.74 3014 15.04 5838 44.59 6680 68.14 15,966 21.14 15,966 20.19

Other upper respiratory disease
 Both sexes 9184 23.82 4597 19.18 8436 22.24 5339 21.71 3941 22.73 31,497 22.12 31,497 22.10
 Men 5033 25.66 1765 17.08 3470 19.40 2221 19.32 1717 22.79 14,206 21.25 14,206 21.16
 Women 4151 21.91 2832 20.78 4966 24.78 3118 23.82 2224 22.69 17,291 22.90 17,291 22.99

Anxiety, depression, and bipolar disorders
 Both sexes 2559 6.64 5577 23.27 9927 26.17 6127 24.92 4156 23.97 28,346 19.91 28,346 19.75
 Men 1179 6.01 1775 17.17 3453 19.30 2139 18.61 1346 17.87 9892 14.79 9892 15.09
 Women 1380 7.28 3802 27.89 6474 32.31 3988 30.46 2810 28.67 18,454 24.44 18,454 24.13

Chronic neurologic disorders
 Both sexes 2774 7.19 2812 11.73 7482 19.73 6829 27.77 8324 48.02 28,221 19.82 28,221 19.75
 Men 1519 7.75 995 9.63 2929 16.37 2894 25.17 3412 45.29 11,749 17.57 11,749 17.92
 Women 1255 6.62 1817 13.33 4553 22.72 3935 30.06 4912 50.11 16,472 21.81 16,472 21.43

Hypertension
 Both sexes 108 0.28 513 2.14 4450 11.73 8918 36.27 12,251 70.67 26,240 18.43 26,240 18.21
 Men 64 0.33 269 2.60 2444 13.66 4514 39.27 5290 70.22 12,581 18.82 12,581 19.22
 Women 44 0.23 244 1.79 2006 10.01 4404 33.64 6961 71.01 13,659 18.09 13,659 17.22

Headaches; including migraines
 Both sexes 3286 8.52 4135 17.25 6753 17.81 3745 15.23 2302 13.28 20,221 14.20 20,221 13.99
 Men 1446 7.37 1020 9.87 1918 10.72 1162 10.11 766 10.17 6312 9.44 6312 9.53
 Women 1840 9.71 3115 22.85 4835 24.13 2583 19.73 1536 15.67 13,909 18.42 13,909 18.32

Diabetes
 Both sexes 221 0.57 724 3.02 4181 11.02 6897 28.05 7872 45.41 19,895 13.97 19,895 13.78
 Men 108 0.55 241 2.33 2091 11.69 3658 31.82 3723 49.42 9821 14.69 9821 14.94
 Women 113 0.60 483 3.54 2090 10.43 3239 24.74 4149 42.32 10,074 13.34 10,074 12.82

Arrhythmias
 Both sexes 750 1.95 1689 7.05 3874 10.21 4403 17.91 7988 46.08 18,704 13.14 18,704 13.03
 Men 348 1.78 584 5.65 1574 8.80 2227 19.37 3826 50.79 8559 12.80 8559 13.21
 Women 402 2.12 1105 8.11 2300 11.48 2176 16.62 4162 42.46 10,145 13.43 10,145 13.05

Esophageal disorders
 Both sexes 1462 3.79 1260 5.26 3973 10.48 3973 16.16 4117 23.75 14,785 10.38 14,785 10.36
 Men 792 4.04 499 4.83 1860 10.40 1765 15.35 1700 22.57 6616 9.89 6616 10.08
 Women 670 3.54 761 5.58 2113 10.54 2208 16.87 2417 24.66 8169 10.82 8169 10.59

Asthma
 Both sexes 4141 10.74 2108 8.80 3125 8.24 1951 7.94 1424 8.21 12,749 8.95 12,749 8.88
 Men 2382 12.15 716 6.93 1043 5.83 630 5.48 493 6.55 5264 7.87 5264 7.75
 Women 1759 9.28 1392 10.21 2082 10.39 1321 10.09 931 9.50 7485 9.91 7485 9.91

Thyroid disorders
 Both sexes 305 0.79 963 4.02 3546 9.35 3732 15.18 4283 24.71 12,829 9.01 12,829 8.87
 Men 106 0.54 150 1.45 638 3.57 789 6.86 1091 14.48 2774 4.15 2774 4.27
 Women 199 1.05 813 5.96 2908 14.51 2943 22.48 3192 32.56 10,055 13.32 10,055 13.00

Deficiency and other anemia
 Both sexes 868 2.25 1040 4.34 2803 7.39 2751 11.19 5148 29.70 12,610 8.86 12,610 8.75
 Men 406 2.07 163 1.58 582 3.25 997 8.67 2161 28.69 4309 6.44 4309 6.65
 Women 462 2.44 877 6.43 2221 11.08 1754 13.40 2987 30.47 8301 10.99 8301 10.79

Bowel disorders
 Both sexes 481 1.25 630 2.63 1843 4.86 4525 18.40 5195 29.97 12,674 8.90 12,674 8.68
 Men 253 1.29 243 2.35 937 5.24 2338 20.34 2459 32.64 6230 9.32 6230 9.39
 Women 228 1.20 387 2.84 906 4.52 2187 16.71 2736 27.91 6444 8.53 6444 8.09

Cancerd
 Both sexes 94 0.24 397 1.66 1887 4.98 3272 13.31 6334 36.54 11,984 8.42 11,984 8.28
 Men 52 0.27 85 0.82 630 3.52 1483 12.90 3202 42.51 5452 8.15 5452 7.62
 Women 42 0.22 312 2.29 1257 6.27 1789 13.67 3132 31.95 6532 8.65 6532 8.92

Biliary and liver disorders
 Both sexes 1141 2.96 795 3.32 3207 8.46 3392 13.80 3243 18.71 11,778 8.27 11,778 8.23
 Men 599 3.05 242 2.34 1456 8.14 1459 12.69 1443 19.16 5199 7.78 5199 7.93
 Women 542 2.86 553 4.06 1751 8.74 1933 14.77 1800 18.36 6579 8.71 6579 8.53

Obstructive pulmonary disorders
 Both sexes 1738 4.51 1132 4.72 2816 7.43 2506 10.19 3263 18.82 11,455 8.05 11,455 8.00
 Men 910 4.64 352 3.41 1089 6.09 1097 9.54 1466 19.46 4914 7.35 4914 7.47
 Women 828 4.37 780 5.72 1727 8.62 1409 10.76 1797 18.33 6541 8.66 6541 8.56

Ischemic heart disease
 Both sexes 164 0.43 156 0.65 1107 2.92 3084 12.54 6833 39.42 11,344 7.97 11,344 7.87
 Men 88 0.45 102 0.99 631 3.53 1895 16.48 3513 46.64 6229 9.32 6229 9.60
 Women 76 0.40 54 0.40 476 2.38 1189 9.08 3320 33.87 5115 6.77 5115 6.45
a

Numbers to the left of the prevalence figure indicate the actual number of cases observed. Prevalence can be computed by dividing the number of cases by the corresponding denominator listed below (and multiplying by 100)

Denominators for men and women combined: 0–18=38,558; 19–29=23,968; 30–49=37,927; 50–64=24,588; 65+=17,336

Denominators for men: 0–18=19,611; 19–29=10,337; 30–49=17,888; 50–64=11,496; 65+=7533

Denominators for women: 0–18=18,947; 19–29=13,631; 30–49=20,039; 50–64=13,092; 65+=9803

b

A crude prevalence was computed by dividing cases observed across all ages by the total population

c

Overall prevalence for men and women combined was standardized by age and sex; overall prevalence for men and women separately was standardized only by age (direct standardization using the 2000 US census population)

d

Prevalence for men excluded women’s cancers (ovarian, uterine, etc.) and prevalence for women excluded men’s cancers (prostate, testicular, etc.)